Holen Sie sich die Stockscreener-App
0.00
100.00%
-0.41
Handel nachbörslich:
.35
0.35
+
Schlusskurs vom Vortag:
$0.41
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$2.15M
Einnahmen:
$4.17M
Nettoeinkommen (Verlust:
$-27.71M
KGV:
0.00
EPS:
-0.37
Netto-Cashflow:
$-22.23M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$0.00
$0.00
52-Wochen-Spanne:
$0.00
$17.10
Clearside Biomedical Inc Stock (CLSD) Company Profile
Firmenname
Clearside Biomedical Inc
Sektor
Branche
Telefon
678-270-3631
Adresse
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Vergleichen Sie CLSD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
0.00 | 2.15M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.48 | 116.04B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.36 | 75.97B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
458.12 | 61.48B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
901.17 | 56.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
204.00 | 43.73B | 447.02M | -1.18B | -906.14M | -6.1812 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-18 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2025-07-18 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-07-18 | Herabstufung | Stifel | Buy → Hold |
| 2024-08-21 | Eingeleitet | Chardan Capital Markets | Buy |
| 2024-06-25 | Eingeleitet | Oppenheimer | Outperform |
| 2021-12-15 | Fortgesetzt | Wedbush | Outperform |
| 2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-05-13 | Eingeleitet | ROTH Capital | Buy |
| 2019-08-09 | Herabstufung | Needham | Buy → Hold |
| 2018-11-05 | Herabstufung | Cowen | Outperform → Market Perform |
| 2018-11-05 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2018-11-05 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-06 | Bestätigt | Needham | Buy |
| 2017-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2017-02-24 | Eingeleitet | JP Morgan | Overweight |
| 2016-11-10 | Bestätigt | Needham | Buy |
| 2016-10-24 | Bestätigt | Stifel | Buy |
Alle ansehen
Clearside Biomedical Inc Aktie (CLSD) Neueste Nachrichten
Preferred dividends of Clearside Biomedical, Inc. – OTC:CLSDQ - TradingView
What date does Clearside Biomedical's (CLSDQ) report EarningsEarnings Calendar & Announcement - Zacks Investment Research
Clearside Biomedical, Inc. (CLSDQ) stock price, news, quote and history - Yahoo Finance UK
How Clearside Biomedical Inc. (CLM) stock stacks up against competitors2025 Winners & Losers & Fast Exit and Entry Strategy Plans - Newser
Is Clearside Biomedical Inc. (CLM) stock undervalued at current priceJuly 2025 Trends & Community Consensus Trade Alerts - Newser
How Clearside Biomedical Inc. (CLM) stock performs in easing cyclesWeekly Volume Report & Low Risk Entry Point Tips - Newser
Is Clearside Biomedical Inc. stock positioned for digital transformation2025 Key Highlights & High Return Stock Watch Alerts - Newser
Clearside Biomedical (CLSDQ) Earnings Yield (TTM) - Zacks Investment Research
CLSDQ: Clearside BiomedicalBrokerage Recommendations Chart - Zacks Investment Research
Clearside Biomedical (CLSDQ) Dividend (TTM) - Zacks Investment Research
Clearside Biomedical (CLSDQ) Price To Cash Flow - Zacks Investment Research
Clearside Biomedical (CLSDQ) Total Liabilities - Zacks Investment Research
Clearside Biomedical (CLSDQ) - Zacks Investment Research
Clearside Biomedical (CLSDQ) Free Cash Flow (TTM) - Zacks Investment Research
Clearside Biomedical (CLSDQ) Debt Equity Ratio (Quarterly) - Zacks Investment Research
Why Clearside Biomedical Inc. (CLM) stock trades below fair valuePortfolio Return Summary & Weekly Momentum Picks - Newser
Is Clearside Biomedical Inc. (CLM) stock attractive for dividend growthQuarterly Trade Report & Comprehensive Market Scan Insights - Newser
Clearside Biomedical (CLSDQ) Profit Margin (Quarterly) - Zacks Investment Research
Clearside Biomedical, Inc. Financial Disclosures & SEC Filings - TradingView
Technical Analysis of Clearside Biomedical, Inc. (OTC:CLSDQ) - TradingView
Clearside Biomedical Inc (CLSDQ) valuation measures and financial statistics - Yahoo Finance Singapore
Clearside Biomedical Inc (CLSDQ) Stock Earnings Transcripts - GuruFocus
Clearside Biomedical Inc (CLSDQ) SEC filings - GuruFocus
CLSDQ (Clearside Biomedical) Change In Prepaid Assets : $-0.20 Mil (TTM As of Sep. 2025) - GuruFocus
Is Clearside Biomedical Inc. (CLM) stock supported by strong fundamentalsQuarterly Growth Report & Verified Trade Idea Suggestions - Newser
Can Clearside Biomedical Inc. (CLM) stock beat analyst consensusPortfolio Value Summary & Real-Time Stock Entry Alerts - Newser
Clearside Biomedical, Inc. Earnings and Revenue – OTC:CLSDQ - TradingView
CLSDQ Stock Price and Chart — OTC:CLSDQ - TradingView
Clearside Biomedical, Inc. Revenue Breakdown – OTC:CLSDQ - TradingView
Meet The Attorneys Leading Clearside Biomedical's Ch. 11 - Law360
News On Clearside Biomedical Inc. (CLSD) Now Under CLSDQ - 富途牛牛
A better buy-in window may exist right now for Clearside Biomedical Inc (CLSD) - Setenews
Clearside Biomedical (CLSD) Options Delisted as of December 1 - GuruFocus
Published on: 2025-11-30 08:17:47 - BỘ NỘI VỤ
What drives Clearside Biomedical Inc stock priceDay Trading Setups & Explosive Growth Opportunities - earlytimes.in
Why Clearside Biomedical Inc. stock remains on buy listsInsider Selling & Long-Term Growth Plans - BỘ NỘI VỤ
Clearside Biomedical, Inc.(NasdaqGM: CLSD) dropped from S&P TMI Index - marketscreener.com
Is Clearside Biomedical Inc CLM a good long term investmentMarket Volatility Update & Superior Trading Ideas - earlytimes.in
Clearside Biomedical, Inc.(OTCPK: CLSD.Q) dropped from NASDAQ Composite Index - marketscreener.com
Clearside Biomedical Faces Delisting After Bankruptcy Filing - MSN
Why Is Clearside Biomedical Stock (CLSD) Down Today? - MSN
Clearside Biomedical to pursue sale of business via Chapter 11 process - MSN
Catching Up With New Bankruptcy Case Action - Law360
Biomedical Co. Gets First-Day Ch. 11 Relief Amid Sale Push - Law360
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Health Care Stocks Climb As Inspire Medical Shines - Finimize
Stocks of Clearside Biomedical Inc (CLSD) are poised to climb above their peers - Setenews
Key medical device brand for files Chapter 11 bankruptcy - TheStreet
Clearside Biomedical to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process - VisionMonday.com
CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy - ts2.tech
Clearside Biomedical files for Chapter 11 bankruptcy protection By Investing.com - Investing.com Australia
Finanzdaten der Clearside Biomedical Inc-Aktie (CLSD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.44%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):